Economic evaluation of the utilization of telemedicine for patients with cardiovascular disease: a systematic review
Tóm tắt
Từ khóa
Tài liệu tham khảo
Azizi F, Hatami H, Janghorbani M (2000) Epidemiology and control of common diseases in Iran, 1st edn. Ministry of Health Publications, Tehran
Chen M, Chun H, Miller IDC, Torfs T, Lin Q, Van Hoof C et al (2019) A 400 GΩ input-impedance active electrode for non-contact capacitively coupled ECG acquisition with large linear-input-range and high CM-interference-tolerance. IEEE Trans Biomed Circuits Syst. https://doi.org/10.1109/TBCAS.2019.2895660
Rubinstein A, Colantonio L, Bardach A, Caporale J, Martí SG, Kopitowski K, Alcaraz A, Gibbons L, Augustovski F, Pichón-Rivière A (2010) Estimation of the burden of cardiovascular disease attributable to modifiable risk factors and cost-effectiveness analysis of preventative interventions to reduce this burden in Argentina. BMC Public Health 10(1):627–615. https://doi.org/10.1186/1471-2458-10-627
Bloom DE, Cafiero E, Jané-Llopis E, Abrahams-Gessel S, Bloom LR, Fathima S et al (2012) The global economic burden of noncommunicable diseases. Program on the Global Demography of Aging
Leal J, Luengo-Fernandez R, Gray A, Petersen S, Rayner M (2006) Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J 27(13):1610–1619
Samavat T, Hojatzadeh E, ShamsM AA, Mahdavi A, Bashti S (2013) Methods of prevention and control cardio vascular disease. Tehran, Mehravesh
Hsiao C-C, Jui-Peng T, Sung K-T, Lee P-Y, Lo C-I, Huang W-H et al (2017) Telemedicine in cardiovascular disease 內科學誌 . 28(3):133-9. https://doi.org/10.6314/JIMT.2017.28(3).03
golamhosseieni, l., Sadeghi M, Mehrabi N (2011) Dimensional evaluation of telemedicine. JPF, 4, 36–43. Retrieved from http://eprints.ajaums.ac.ir/id/eprint/1485
Rezabeigi davarani E, Iranpour A, Khanjani N, Mohseni M, Nazari Robati F (2016) Cardiovascular diseases risk factors and the relationship between knowledge level and preventive behaviors for cardiovascular diseases among women in Kerman. Health-Based Res 2(2):119–132
Wootton R (1998) Telemedicine in the national health service. J R Soc Med 91(12):614–621. https://doi.org/10.1177/014107689809101202
Wade V, Stocks N (2017) The use of telehealth to reduce inequalities in cardiovascular outcomes in Australia and New Zealand: a critical review. Heart Lung Circ 26(4):331–337. https://doi.org/10.1016/j.hlc.2016.10.013
Cichosz SL, Ehlers LH, Hejlesen O (2016) Health effectiveness and cost-effectiveness of telehealthcare for heart failure: study protocol for a randomized controlled trial. Trials 17(1):590–596. https://doi.org/10.1186/s13063-016-1722-5
H J (2010) Longterm cost-effectiveness analysis of a telemedicine programme for patients with chronic heart failure. Eur Heart J
Kaambwa B, Bryan S, Jowett S, Mant J, Bray EP, Hobbs FR et al (2014) Telemonitoring and self-management in the control of hypertension (TASMINH2): a cost-effectiveness analysis. Eur J Prev Cardiol 21(12):1517–1530. https://doi.org/10.1177/2047487313501886
Perednia DA, Allen A (1995) Telemedicine technology and clinical applications. JAMA 273(6):483–488. https://doi.org/10.1001/jama.1995.03520300057037
Raatikainen MP, Uusimaa P, van Ginneken MM, Janssen JP, Linnaluoto M (2008) Remote monitoring of implantable cardioverter defibrillator patients: a safe, time-saving, and cost-effective means for follow-up. Europace. 10(10):1145–1151. https://doi.org/10.1093/europace/eun203
Sohn S, Helms TM, Pelleter JT, Müller A, Kröttinger AI, Schöffski O (2012) Costs and benefits of personalized healthcare for patients with chronic heart failure in the care and education program “Telemedicine for the Heart”. Telemed E Health 18(3):198–204. https://doi.org/10.1089/tmj.2011.0134
Henderson C, Knapp M, Fernández J-L, Beecham J, Hirani SP, Cartwright M et al (2013) Cost effectiveness of telehealth for patients with long term conditions (Whole Systems Demonstrator telehealth questionnaire study): nested economic evaluation in a pragmatic, cluster randomised controlled trial. BMJ 346:f1035. https://doi.org/10.1136/bmj.f1035
Stoddart A, Hanley J, Wild S, Pagliari C, Paterson M, Lewis S et al (2013) Telemonitoring-based service redesign for the management of uncontrolled hypertension (HITS): cost and cost-effectiveness analysis of a randomised controlled trial. BMJ Open 3(5):e002681. https://doi.org/10.1136/bmjopen-2013-002681
Madsen LB, Christiansen T, Kirkegaard P, Pedersen EB (2011) Economic evaluation of home blood pressure telemonitoring: a randomized controlled trial. Blood Press 20(2):117–125. https://doi.org/10.3109/08037051.2010.532306
Frederix I, Solmi F, Piepoli MF, Dendale P (2017) Cardiac telerehabilitation: a novel cost-efficient care delivery strategy that can induce long-term health benefits. Eur J Prev Cardiol 24(16):1708–1717. https://doi.org/10.1177/2047487317732274
Cowie MR, Simon M, Klein L, Thokala P (2017) The cost-effectiveness of real-time pulmonary artery pressure monitoring in heart failure patients: a European perspective. Eur J Heart Fail 19(5):661–669. https://doi.org/10.1002/ejhf.747
Zanaboni P, Landolina M, Marzegalli M, Lunati M, Perego GB, Guenzati G et al (2013) Cost-utility analysis of the EVOLVO study on remote monitoring for heart failure patients with implantable defibrillators: randomized controlled trial. J Med Internet Res 15(5). https://doi.org/10.2196/jmir.2587
Hailey D, Yu P (2013) Cost–effectiveness of telehealth in the management of chronic conditions. J Comp Eff Res 2(4):379–381. https://doi.org/10.2217/cer.13.41
Smith B, Hughes-Cromwick PF, Forkner E, Galbreath AD (2008) Cost-effectiveness of telephonic disease management in heart failure. Am J Manag Care 14(2):106–115
Cheng Q, Church J, Haas M, Goodall S, Sangster J, Furber S (2016) Cost-effectiveness of a population-based lifestyle intervention to promote healthy weight and physical activity in non-attenders of cardiac rehabilitation. Heart Lung Circ 25(3):265–274
Dixon P, Hollinghurst S, Edwards L, Thomas C, Gaunt D, Foster A et al (2016) Cost-effectiveness of telehealth for patients with raised cardiovascular disease risk: evidence from the Healthlines randomised controlled trial. BMJ Open 6(8):e012352. https://doi.org/10.1136/bmjopen-2016-012352
Grustam AS, Severens JL, De Massari D, Buyukkaramikli N, Koymans R, Vrijhoef HJ (2018) Cost-effectiveness analysis in telehealth: a comparison between home telemonitoring, nurse telephone support, and usual care in chronic heart failure management. Value Health 21(7):772–782. https://doi.org/10.1016/j.jval.2017.11.011
Dixon P, Hollinghurst S, Ara R, Edwards L, Foster A, Salisbury C (2016) Cost-effectiveness modelling of telehealth for patients with raised cardiovascular disease risk: evidence from a cohort simulation conducted alongside the Healthlines randomised controlled trial. BMJ Open 6(9):e012355. https://doi.org/10.1136/bmjopen-2016-012355
Schmier JK, Ong KL, Fonarow GC (2017) Cost-effectiveness of remote cardiac monitoring with the CardioMEMS heart failure system. Clin Cardiol 40(7):430–436. https://doi.org/10.1002/clc.22696
Monahan M, Jowett S, Lovibond K, Gill P, Godwin M, Greenfield S et al (2018) Predicting out-of-office blood pressure in the clinic for the diagnosis of hypertension in primary care: an economic evaluation. Hypertension 71(2):250–261. https://doi.org/10.1161/HYPERTENSIONAHA.117.10244
Keyserling TC, Sheridan SL, Draeger LB, Finkelstein EA, Gizlice Z, Kruger E et al (2014) A comparison of live counseling with a web-based lifestyle and medication intervention to reduce coronary heart disease risk: a randomized clinical trial. JAMA Intern Med 174(7):1144–1157. https://doi.org/10.1001/jamainternmed.2014.1984
Kraal JJ, Van den Akker-Van Marle ME, Abu-Hanna A, Stut W, Peek N, Kemps HM (2017) Clinical and cost-effectiveness of home-based cardiac rehabilitation compared to conventional, centre-based cardiac rehabilitation: results of the FIT@ Home study. Eur J Prev Cardiol 24(12):1260–1273. https://doi.org/10.1177/2047487317710803
Boyne JJ, Di Van Asselt A, Gorgels AP, Steuten LM, De Weerd G, Kragten J et al (2013) Cost–effectiveness analysis of telemonitoring versus usual care in patients with heart failure: the TEHAF–study. J Telemed Telecare 19(5):242–248. https://doi.org/10.1177/1357633X13495478
Frederix I, Hansen D, Coninx K, Vandervoort P, Vandijck D, Hens N et al (2016) Effect of comprehensive cardiac telerehabilitation on one-year cardiovascular rehospitalization rate, medical costs and quality of life: a cost-effectiveness analysis. Eur J Prev Cardiol 23(7):674–682. https://doi.org/10.1177/2047487315602257
Salisbury C, O’Cathain A, Thomas C, Edwards L, Gaunt D, Dixon P et al (2016) Telehealth for patients at high risk of cardiovascular disease: pragmatic randomised controlled trial. BMJ 353:i2647. https://doi.org/10.1136/bmj.i2647
Maddison R, Pfaeffli L, Whittaker R, Stewart R, Kerr A, Jiang Y, Kira G, Leung W, Dalleck L, Carter K, Rawstorn J (2015) A mobile phone intervention increases physical activity in people with cardiovascular disease: results from the HEART randomized controlled trial. Eur J Prev Cardiol 22(6):701–709
Thokala P, Hassan B, Abdullah P, Stevens J, Alan B (2013) Cost-effectiveness modelling of telemonitoring after discharge from hospital with heart failure. Int J Integr Care. 13(7)
Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D et al (2013) Consolidated health economic evaluation reporting standards (CHEERS)—explanation and elaboration: a report of the ISPOR health economic evaluation publication guidelines good reporting practices task force. Value Health 16(2):231–250
Hope SF, Webster J, Trieu K, Pillay A, Ieremia M, Bell C et al (2017) A systematic review of economic evaluations of population-based sodium reduction interventions. PLoS One 12(3):e0173600. https://doi.org/10.1371/journal.pone.0173600
Van Dyck W, Vértes G, Palaniappan M, Gassull D, Jain P, Schulthess D et al (2012) Acute coronary syndrome: What is the cost-effectiveness of prevention, point-of-care technology and telemonitoring? HPTJ 1(3):173–177. https://doi.org/10.1016/j.hlpt.2012.07.002